Friday 6 November 2026 Export COO’s income statement to Excel — free account

The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.

Revenue: +0.56%
EPS: +357.1%
Free cash flow: +66.0%
Total debt: +2.66%

Quarter to July 2026, against a year earlier

63.44 0.98 −1.52%

Follow COO

Alert me

Market cap: $12.1B
P/E: 21.7×
Fwd P/E: 17.5×
Dividend yield: —
F-score: 5/9
Altman Z: 3.48
Beneish M: −2.50
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

The Cooper Companies, Inc. (COO) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
CooperVision	2,744	67.05%
CooperSurgical	1,349	32.95%
Gross margin		65.54%
Operating margin		16.69%
Pre-tax margin		13.84%

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
CooperVision	2,744 67.05%	2,609 66.99%	2,424 67.45%	2,243 67.81%	2,152 73.64%	—	—	—	—	—	—	—	—	—	—	—
CooperSurgical	1,349 32.95%	1,286 33.01%	1,170 32.55%	1,065 32.19%	771 26.36%	—	—	—	—	—	—	—	—	—	—	—
Corporate	—	—	—	—	—	—	—	—	—	0 0.00%	0 0.00%	0 0.00%	0 0.00%	0 0.00%	0 0.00%	—
Coopervision Inc	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	970 83.77%
Intersegment Eliminations	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0 0.00%
Also reported: a second breakdown of the same revenue
Coopervision Segment	2,744 67.05%	2,609 66.99%	2,424 67.45%	2,243 67.81%	—	1,843 75.82%	1,973 74.35%	1,882 74.31%	1,674 78.27%	1,577 80.19%	1,488 82.79%	1,393 81.07%	1,268 79.88%	1,189 82.29%	1,121 84.24%	—
Coopersurgical Segment	1,349 32.95%	1,286 33.01%	1,170 32.55%	1,065 32.19%	—	588 24.18%	681 25.65%	651 25.69%	465 21.73%	390 19.81%	309 17.21%	325 18.93%	319 20.12%	256 17.71%	210 15.76%	188 16.23%
Revenue	4,092	3,895	3,593	3,308	2,923	2,431	2,653	2,533	2,139	1,967	1,797	1,718	1,588	1,445	1,331	1,159

Operating income by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
CooperVision	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
CooperSurgical	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Coopervision Segment	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Coopersurgical Segment	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Corporate	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Coopervision Inc	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Intersegment Eliminations	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Corporate and other	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Operating income	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

Revenue by region $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
United States	2,054 50.19%	1,966 50.47%	1,812 50.43%	1,639 49.53%	1,339 45.82%	1,104 45.40%	1,212 45.67%	1,162 45.89%	1,187 55.48%	1,141 58.02%	1,062 59.09%	1,004 58.47%	973 61.26%	879 60.85%	800 60.12%	713 61.52%	638 59.09%
Europe	1,253 30.62%	1,156 29.67%	1,041 28.98%	987 29.84%	958 32.78%	790 32.49%	855 32.22%	847 33.42%	1,187 55.48%	1,145 58.23%	1,140 63.46%	928 54.05%	805 50.73%	727 50.31%	697 52.35%	647 55.84%	612 56.63%
Rest of world	785 19.19%	774 19.86%	740 20.59%	683 20.64%	625 21.40%	538 22.11%	587 22.12%	524 20.69%	(234) (10.96%)	(320) (16.25%)	(405) (22.55%)	(215) (12.52%)	(190) (11.99%)	(161) (11.16%)	(166) (12.47%)	(201) (17.36%)	(170) (15.72%)
Revenue	4,092	3,895	3,593	3,308	2,923	2,431	2,653	2,533	2,139	1,967	1,797	1,718	1,588	1,445	1,331	1,159	1,080

Operating income by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Rest of world	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
United States	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Europe	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Operating income	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.

The Cooper Companies, Inc. (COO) revenue by segment, product and region

Where the money comes from and where it goes

Revenue by segment $m

Operating income by segment $m, and margin

Revenue by region $m

Operating income by segment $m, and margin

Stockrow Weekly